CA2580802C - Medicinal disulfide salts - Google Patents

Medicinal disulfide salts Download PDF

Info

Publication number
CA2580802C
CA2580802C CA2580802A CA2580802A CA2580802C CA 2580802 C CA2580802 C CA 2580802C CA 2580802 A CA2580802 A CA 2580802A CA 2580802 A CA2580802 A CA 2580802A CA 2580802 C CA2580802 C CA 2580802C
Authority
CA
Canada
Prior art keywords
group
compound
formula
ion
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2580802A
Other languages
English (en)
French (fr)
Other versions
CA2580802A1 (en
Inventor
Qiuli Huang
Harry Kochat
Xinghai Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioNumerik Pharmaceuticals Inc
Original Assignee
BioNumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNumerik Pharmaceuticals Inc filed Critical BioNumerik Pharmaceuticals Inc
Publication of CA2580802A1 publication Critical patent/CA2580802A1/en
Application granted granted Critical
Publication of CA2580802C publication Critical patent/CA2580802C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2580802A 2004-09-21 2005-09-21 Medicinal disulfide salts Expired - Fee Related CA2580802C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/945,809 US7282602B2 (en) 2004-09-21 2004-09-21 Medicinal disulfide salts
US10/945,809 2004-09-21
PCT/US2005/033774 WO2006034327A1 (en) 2004-09-21 2005-09-21 Medicinal disulfide salts

Publications (2)

Publication Number Publication Date
CA2580802A1 CA2580802A1 (en) 2006-03-30
CA2580802C true CA2580802C (en) 2012-11-20

Family

ID=36074969

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2580802A Expired - Fee Related CA2580802C (en) 2004-09-21 2005-09-21 Medicinal disulfide salts

Country Status (7)

Country Link
US (1) US7282602B2 (https=)
EP (1) EP1797031A4 (https=)
JP (1) JP5015781B2 (https=)
CN (1) CN101076513A (https=)
CA (1) CA2580802C (https=)
MX (1) MX2007003174A (https=)
WO (1) WO2006034327A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011067653A1 (en) * 2009-12-04 2011-06-09 Carlo Ghisalberti Oral compositions for use in the mercury intoxication from dental amalgam
JP6271233B2 (ja) * 2013-11-29 2018-01-31 ローム・アンド・ハース電子材料株式会社 表面処理液
WO2015106240A1 (en) 2014-01-13 2015-07-16 The General Hospital Corporation Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin
MX2022008481A (es) * 2020-01-10 2022-10-27 Lantern Pharma Inc Metodo para determinar la sensibilidad al 2,2'-ditio-bis-etano sulfonato.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE593047A (https=) * 1959-07-17
DE2025538A1 (de) * 1970-04-02 1971-10-21 Lokomotivbau Elektrotech Verfahren zur galvanischen Glanzverkupferung aus sauren Elektrolyten
BE788685A (nl) * 1971-09-13 1973-03-12 Agfa Gevaert Nv Ontwikkeling van contrastrijke zilverhalogenide-emulsies voor grafischedoeleinden
DD122086A1 (https=) * 1975-06-16 1976-09-12
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
DE4032864A1 (de) * 1990-10-13 1992-04-16 Schering Ag Saures bad zur galvanischen abscheidung von kupferueberzuegen und verfahren unter verwendung dieser kombination
DE4127821A1 (de) * 1991-08-23 1993-02-25 Basf Ag Disulfide, verfahren zu deren herstellung und deren verwendung
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
US5661188A (en) * 1995-06-07 1997-08-26 Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)
ES2170414T3 (es) * 1996-09-23 2002-08-01 Bionumerik Pharmaceuticals Inc Reduccion de efectos toxicos del carboplatino usando ditioeteres.
CN1082047C (zh) * 1996-10-01 2002-04-03 比奥纽默里克药物公司 生产巯基链烷磺酸盐和磷酸盐及其衍生物的方法
US6160167A (en) * 1998-04-21 2000-12-12 Bionumerik Pharmaceuticals, Inc. Mercaptans and disulfides
JP3124523B2 (ja) * 1999-01-28 2001-01-15 日本エレクトロプレイテイング・エンジニヤース株式会社 銅メッキ方法
KR20020029626A (ko) * 2000-10-13 2002-04-19 마티네즈 길러모 전해질
JP2003072231A (ja) * 2001-09-06 2003-03-12 Oji Paper Co Ltd インクジェット記録用シート
US6504049B1 (en) * 2002-04-30 2003-01-07 Bionumerik Pharmaceuticals, Inc. Process for synthesizing pharmaceutically active disulfide salts
EP1607495A4 (en) * 2002-12-25 2006-07-12 Nikko Materials Co Ltd COPPER ELECTROLYTE SOLUTION CONTAINS A QUINTERNATIVE AMINO-BONDED POLYMER COMPRISING A PARTICULAR SCAFFOLD AND ORGANIC SULFUR COMPOUND AS ADDITIONS AND ELECTROLYTIC COPPER FOIL MANUFACTURED THEREWITH
JP2005048256A (ja) * 2003-07-30 2005-02-24 Asahi Denka Kogyo Kk 銅メッキ用添加剤、銅メッキ浴および銅メッキ方法
JP2006104134A (ja) * 2004-10-06 2006-04-20 Asahi Denka Kogyo Kk ジスルフィド類の製造方法
JP4750486B2 (ja) * 2005-07-06 2011-08-17 株式会社Adeka 電解銅メッキ用添加剤、該添加剤を含有する電解銅メッキ浴及び該メッキ浴を使用する電解銅メッキ方法

Also Published As

Publication number Publication date
WO2006034327A1 (en) 2006-03-30
US7282602B2 (en) 2007-10-16
CN101076513A (zh) 2007-11-21
MX2007003174A (es) 2008-01-11
EP1797031A4 (en) 2009-12-16
US20060063949A1 (en) 2006-03-23
CA2580802A1 (en) 2006-03-30
EP1797031A1 (en) 2007-06-20
JP2008513503A (ja) 2008-05-01
JP5015781B2 (ja) 2012-08-29

Similar Documents

Publication Publication Date Title
CZ129794A3 (en) Organic salts of n,n'-diacetylcystine
US4981869A (en) Xanthates as antitumor agents
US6160167A (en) Mercaptans and disulfides
KR0178794B1 (ko) 산화형 글루타티온 알킬 에스테르
CA2580802C (en) Medicinal disulfide salts
ES2523653T3 (es) Procedimiento para sintetizar sales de disulfuro farmacéuticamente activas
US7829539B2 (en) Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
IT8520338A1 (it) Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attività terapeutica, derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione.
FI111074B (fi) Menetelmä nitraattoalkaanikarboksyylihappojohdannaisten valmistamiseksi
PL184861B1 (pl) Środek farmaceutyczny do leczenia choróbĆ zwłaszcza grzybicĆ dipeptyd i sposób wytwarzania dipeptydu
FR2640269A1 (fr) Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
JPH054951A (ja) １，４−ジヒドロナフトキノン誘導体およびその製造方法
EP0326326B1 (en) Cysteine derivatives
KR960029319A (ko) 4-아미노벤조일구아니딘 유도체
IE883418L (en) Cysteine derivatives
CA1174978A (en) Xanthates
US4356306A (en) Water-soluble derivatives of 6,6'-methylene-bis-(2,2,4-trimethyl-1,2-dihydroquinoline)
US6686394B1 (en) Aryl-chloro-ethyl ureas
EP0129628A1 (fr) Médicament, utilisable notamment en psychiatrie, utilisant comme principe actif un N- alkylcarbamoylphosphate de lithium
CS227333B2 (cs) Způsob výroby solí alkalických kovů sulfonových kyselin a sulfonamidových derivátů 6,6-methylen-bis(2,2,4-trimethyl-1,2-dihydrochinolinu) a jejich dimerových a triměrových kondenzačních produktů
KR980009255A (ko) 간장질환 치료 및 예방에 유용한 화합물의 신규 유기염류 및 그 제조방법
IE41495B1 (en) Dihydroapovincaminic acid amide

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220322

MKLA Lapsed

Effective date: 20200921